High-Risk Merchant Accounts for Peptide Brands
A high-risk merchant account is a dedicated MID issued by an acquiring bank that has knowingly underwritten your peptide business. Getting approved takes a complete file — entity docs, bank statements, processing history, a finished compliant website, and COAs — and honest disclosure of exactly what you sell. Expect 3.5-6% plus a reserve, and plan for two MIDs from day one.
'high risk' is not an insult and it is not a scarlet letter. it is a banking classification. it means the acquiring bank believes your category carries above-average odds of chargebacks, refunds, or regulatory trouble — so they price for it, hold a reserve, and monitor you more closely. peptides land there for obvious reasons: novel products, health-adjacent claims, an evolving regulatory picture, and high average order values sold to first-time customers over the internet.
once you accept the label instead of trying to dodge it, the path gets simple. you stop hunting for a low-risk processor who will 'let you slip through' and start building the application file that gets you a real account with a bank that wants your business.
who is actually in the stack
operators mix these up constantly and it makes every conversation harder. there are four distinct roles.
- —acquiring bank — the entity taking on your risk and issuing the MID. this is who actually approves or declines you.
- —processor — moves the transaction between the gateway, the card networks, and the bank. sometimes the same company as the acquirer, often not.
- —gateway — the software layer your store talks to (authorize.net, NMI, and similar). this is what makes multi-MID routing possible.
- —ISO / MSP or agent — the broker who packages your file and shops it to acquirers. a good one is worth their margin because they know which banks currently accept the category. a bad one submits your file to twenty banks at once and lights your record on fire.
that last point matters more than people realize. shotgunning applications creates a trail of declines that later underwriters can see. work with one or two people who actually know the vertical and submit deliberately.
the approval file, item by item
we run this as a checklist because every missing item adds days. gather all of it before anyone submits anything.
- 1.completed merchant application with accurate projected monthly volume, average ticket, and highest ticket
- 2.articles of incorporation or LLC formation docs, plus the EIN confirmation letter from the IRS
- 3.government photo ID and SSN for every owner at 25%+, plus a voided check or bank letter for the settlement account
- 4.three to six months of business bank statements in the exact legal entity name
- 5.three to six months of prior processing statements if you have any history at all
- 6.live website with terms of service, privacy policy, refund and return policy, shipping policy, and a real phone number and physical address
- 7.product pages with clear, accurate descriptions and claims that match what you told the underwriter
- 8.certificates of analysis from your supplier or third-party lab
- 9.a short cover memo explaining the business model, fulfillment method, and how you handle customer support and refunds
that cover memo is underrated. underwriters read hundreds of thin files. one page that clearly explains who buys this, how it ships, and how you keep chargebacks low makes you the easy approval in their stack.
what gets files declined
the decline reasons are boring and repetitive, which is good news — they are almost all preventable.
- —site and application do not match. you described a wellness supplement brand and the homepage makes explicit medical claims.
- —missing policies. no refund policy is an instant flag because it predicts chargebacks.
- —personal bank account instead of a business account in the entity name
- —prior MATCH-list placement not disclosed. they will find it. disclosing it with an explanation is survivable; hiding it is not.
- —unrealistic projections with no history to back them
- —a website still in coming-soon mode or with placeholder text on legal pages
- —no visible customer service contact anywhere on the site
pricing, and what to negotiate
the headline rate is the thing everyone fixates on and the thing that matters least. here is the full cost picture and where the real leverage sits.
- —discount rate: roughly 3.5-6% depending on history and ticket size
- —per-transaction fee: usually $0.20-0.50
- —monthly gateway fee: $25-100
- —chargeback fee: $15-40 per dispute — this adds up faster than the rate does
- —reserve: 5-10%, rolling or capped. the single largest cash flow variable in the whole agreement.
- —monthly minimum and early termination clause — read both
negotiate in this order: reserve structure first (push for capped over rolling), then the volume cap, then chargeback fees, then the rate. a low rate on an account that caps you at $50k/month is worthless if you are about to do $300k.
the volume cap nobody warns you about
most first approvals come with a monthly processing cap. you may be approved for $75k/month even though your plan is $400k. blowing through the cap does not just decline transactions — it triggers a risk review, and risk reviews on a thin file end badly.
- 1.ask for your cap in writing at approval and know the exact number
- 2.watch your month-to-date volume against it weekly, not monthly
- 3.request an increase proactively at 70% of cap, with the last 60 days of clean ratios attached
- 4.if a campaign is about to spike, email your account rep before the spend goes live, not after
we have seen a single winning creative take a brand from $40k to $180k in a month. that is a great problem and a terminated MID if the bank finds out from their monitoring system instead of from you.
margin builds the whole payments layer for med spas going into peptides: underwriting file, MID approvals, gateway routing, and redundancy that holds when a creative actually works. we have run this while a client went from a standing start past 1,200% growth in six months.
keeping the account after you get it
approval is the beginning. accounts get closed for behavior after approval far more often than applications get declined. the ongoing job is simple and mostly operational.
- —hold chargebacks under 0.65% of monthly transaction count — treat 0.9% as an emergency
- —keep refund ratio reasonable; a spiking refund rate reads as product or fulfillment failure
- —never change your product mix materially without telling the processor first
- —keep the website's claims stable — a new landing page with aggressive medical claims can end an account even if the checkout never changed
- —answer risk department emails within 24 hours, always, even if the answer is 'gathering that now'
- —send updated COAs when you change suppliers
your relationship with the risk team is an asset. the brands that survive are the ones the bank has a name and a phone number for.
two MIDs is the standard, not the exception
start the second application at roughly month three of clean processing on the first. you will have real statements by then, which makes the second approval easier and cheaper. keep genuine volume flowing through both so neither goes dormant. both banks know exactly what you sell — this is redundancy, not concealment.
the illegitimate version — shell entities set up to hide the product, or running peptide volume through an account underwritten for something else — is transaction laundering. it is fraud, it ends in MATCH placement, and it can end worse than that. do not do it. none of this is legal advice; consult your attorney before structuring entities or making product claims.
frequently asked questions
why can't i just find a low-risk processor who accepts peptides?
because the classification comes from the acquiring bank's risk model, not from a sales rep's willingness. any processor promising you low-risk pricing on peptides either does not understand what you sell or is planning to place you somewhere you will be dropped from in ninety days. take the high-risk account and the stability that comes with it.
do i need existing processing history to get approved?
no, but it changes your terms. a startup file typically gets a lower volume cap, a higher reserve, and a worse rate. after six clean months you can go back and renegotiate all three, and you should.
will an offshore MID solve my problem?
sometimes, and it comes with real costs: higher rates, settlement delays, currency conversion, and worse authorization rates on US-issued cards — which means declined sales. treat offshore as part of a redundancy strategy or a solution for genuinely international volume, not as your primary US account.
how much reserve should i budget for in cash flow?
model 10% of gross for 180 days until you know your actual terms. at $150k/month that is roughly $90k of your own cash sitting with the bank at steady state. brands that skip this math run out of inventory money in month two while their revenue looks great on paper.
can one bad month get my account closed?
one bad month rarely does it alone. a bad month you did not communicate about, on top of a rising chargeback trend, will. risk teams respond to trajectory and to silence. a proactive email explaining a spike — a viral ad, a shipping delay, a supplier issue — buys enormous goodwill.
what documentation should i keep on hand permanently?
current COAs, your signed merchant agreement with the fee schedule and reserve terms, a copy of every policy page as published, fulfillment and tracking records for at least 180 days, and your monthly chargeback and refund ratios. when risk asks, you want to answer same-day with documents, not promises.
want us to build this for you?
we take high-end med spas from zero to selling peptides — compliant, in-store, and online, in under two weeks.